Duboscq, C., Martinuzzo, M. E., Ceresetto, J., Lopez, M., Barrera, L., Oyhamburu, J., & Stemmelin, G. (2018). The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban. Journal of thrombosis and haemostasis, 16(8), 1626-1631. https://doi.org/10.1111/jth.14158
Chicago-Zitierstil (17. Ausg.)Duboscq, C., M. E. Martinuzzo, J. Ceresetto, M. Lopez, L. Barrera, J. Oyhamburu, und G. Stemmelin. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis 16, no. 8 (2018): 1626-1631. https://doi.org/10.1111/jth.14158.
MLA-Zitierstil (9. Ausg.)Duboscq, C., et al. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis, vol. 16, no. 8, 2018, pp. 1626-1631, https://doi.org/10.1111/jth.14158.